These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27262777)
1. Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength. Liu DM; Zhao L; Liu TT; Jiao PL; Zhao DD; Shih MS; Tao B; Sun LH; Zhao HY; Liu JM Bone; 2016 Sep; 90():50-8. PubMed ID: 27262777 [TBL] [Abstract][Full Text] [Related]
2. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage. Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950 [TBL] [Abstract][Full Text] [Related]
3. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse. Sun W; Shi Y; Lee WC; Lee SY; Long F Bone; 2016 Apr; 85():1-8. PubMed ID: 26780446 [TBL] [Abstract][Full Text] [Related]
4. mTORC2 signaling promotes skeletal growth and bone formation in mice. Chen J; Holguin N; Shi Y; Silva MJ; Long F J Bone Miner Res; 2015 Feb; 30(2):369-78. PubMed ID: 25196701 [TBL] [Abstract][Full Text] [Related]
5. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice. Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809 [TBL] [Abstract][Full Text] [Related]
6. Rictor ablation in BMSCs inhibits bone metastasis of TM40D cells by attenuating osteolytic destruction and CAF formation. Liu Z; Wang H; He J; Yuan X; Sun W Int J Biol Sci; 2019; 15(11):2448-2460. PubMed ID: 31595162 [TBL] [Abstract][Full Text] [Related]
7. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts. Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811 [TBL] [Abstract][Full Text] [Related]
8. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells. Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655 [TBL] [Abstract][Full Text] [Related]
9. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
10. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts. Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845 [TBL] [Abstract][Full Text] [Related]
12. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells. Zheng B; Wang J; Tang L; Shi J; Zhu D Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249 [TBL] [Abstract][Full Text] [Related]
13. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development. Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826 [TBL] [Abstract][Full Text] [Related]
14. Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling. Liu L; Le PT; Stohn JP; Liu H; Ying W; Baron R; Rosen CJ J Bone Miner Res; 2024 Aug; 39(8):1188-1199. PubMed ID: 38995944 [TBL] [Abstract][Full Text] [Related]
15. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes. Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024 [TBL] [Abstract][Full Text] [Related]
16. MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR. Feng L; Xia B; Tian BF; Lu GB Pharm Biol; 2019 Dec; 57(1):586-594. PubMed ID: 31492082 [No Abstract] [Full Text] [Related]
17. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia. Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811 [TBL] [Abstract][Full Text] [Related]
18. Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice. Liu Y; Almeida M; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL Am J Physiol Endocrinol Metab; 2016 May; 310(9):E762-73. PubMed ID: 26956187 [TBL] [Abstract][Full Text] [Related]
20. Mechanical Vibration Mitigates the Decrease of Bone Quantity and Bone Quality of Leptin Receptor-Deficient Db/Db Mice by Promoting Bone Formation and Inhibiting Bone Resorption. Jing D; Luo E; Cai J; Tong S; Zhai M; Shen G; Wang X; Luo Z J Bone Miner Res; 2016 Sep; 31(9):1713-24. PubMed ID: 26990203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]